Please Wait.....
Report
Europe Remote Patient Monitoring and Care Market - Industry Trends and Forecast to 2030
Market Report I 2023-05-01 I 193 Pages I Data Bridge Market Research
The Europe remote patient monitoring and care market is expected to reach USD 6,258.62 million by 2030 from USD 2,334.95 million in 2022, growing at a CAGR of 14.2% during the forecast period of 2023 to 2030.
Market Segmentation
Europe Remote Patient Monitoring and Care Market, By Device Type (Cardiac Monitoring Devices, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, Respiratory Monitoring Devices, Neurological Monitoring Devices, Multi-Parameter Monitoring Devices, and Others), Application (Oncology, Diabetes, Cardiovascular Diseases, and Others), End User (Hospital Based Patients, Ambulatory Patients, and Home Healthcare Patients), Country (Germany, France, U.K., Italy, Spain, Belgium, Turkey, Netherlands, Russia, Switzerland, and Rest of Europe) - Industry Trends and Forecast to 2030
Overview of Europe Accounts Remote Patient Monitoring and Care Market Dynamics
Driver
- Increasing prevalence of chronic diseases
Restraint
- Stringent regulatory framework
Opportunity
- Strategic initiatives by market players
Market Players:
Some of the major market players operating in the Europe remote patient monitoring and care market are:
- Medtronic
- Boston Scientific Corporation
- VitalConnect
- Biobeat
- General Electric
- Koninklijke Philips N.V.
- OMRON Corporation
- Abbott
- Nihon Kohden Corporation
- Vivify Health, Inc.
- Aerotel Medical Systems
- BIOTRONIK SE & Co. KG
- A&D Company, Limited
- AliveCor, Inc.
- Masimo
- Dexcom, Inc.
- Senseonics, Inc.
- ResMed
- 100Plus.
- ChroniSense Medical, Ltd.
- Vitls
- Cardiomo
- CoachCare
- neteera
- Withings
TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 29
2 MARKET SEGMENTATION 31
2.1 MARKETS COVERED 31
2.2 GEOGRAPHICAL SCOPE 32
2.3 YEARS CONSIDERED FOR THE STUDY 33
2.4 CURRENCY AND PRICING 33
2.5 DBMR TRIPOD DATA VALIDATION MODEL 34
2.6 MULTIVARIATE MODELLING 37
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE 37
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
2.9 DBMR MARKET POSITION GRID 39
2.10 MARKET APPLICATION COVERAGE GRID 40
2.11 VENDOR SHARE ANALYSIS 41
2.12 SECONDARY SOURCES 42
2.13 ASSUMPTIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 PORTER'S FIVE FORCES 47
4.2 VALUE CHAIN ANALYSIS: 48
4.3 COMPETITIVE ANALYSIS 49
4.4 BRAND ANALYSIS 51
4.5 ECOSYSTEM MAPS 52
4.6 TECHNOLOGICAL TRENDS 53
4.7 TOP WINNING STRATEGIES 54
5 MARKET OVERVIEW 55
5.1 DRIVERS 57
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 57
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS 57
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING 59
5.1.4 INCREASING GOVERNMENT INITIATIVES 59
5.2 RESTRAINTS 60
5.2.1 STRICT REGULATORY FRAMEWORK 60
5.2.2 LACK OF STANDARDIZATION 61
5.3 OPPORTUNITIES 61
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 61
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS 62
5.4 CHALLENGES 63
5.4.1 LACK OF SKILLED PROFESSIONALS 63
5.4.2 RISK TO PATIENT'S DATA SECURITY 63
6 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE 65
6.1 OVERVIEW 66
6.2 CARDIAC MONITORING DEVICES 69
6.3 BLOOD PRESSURE MONITORING DEVICES 70
6.4 MULTI-PARAMETER MONITORING DEVICES 71
6.5 BLOOD GLUCOSE MONITORING DEVICES 72
6.6 RESPIRATORY MONITORING DEVICES 73
6.7 NEUROLOGICAL MONITORING DEVICES 74
6.8 OTHERS 75
7 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION 76
7.1 OVERVIEW 77
7.2 CARDIOVASCULAR DISEASE 80
7.2.1 CORONARY HEART DISEASE 81
7.2.2 STROKE 81
7.2.3 PERIPHERAL ARTERIAL DISEASE 81
7.2.4 AORTIC DISEASE 81
7.2.5 OTHERS 81
7.3 DIABETES 81
7.4 ONCOLOGY 82
7.5 OTHERS 83
8 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER 84
8.1 OVERVIEW 85
8.2 HOME HEALTHCARE PATIENTS 88
8.2.1 BLOOD GLUCOSE MONITORING DEVICES 89
8.2.2 CARDIAC MONITORING DEVICES 89
8.2.3 BLOOD PRESSURE MONITORING DEVICES 89
8.2.4 MULTI-PARAMETER MONITORING DEVICES 89
8.2.5 RESPIRATORY MONITORING DEVICES 89
8.2.6 NEUROLOGICAL MONITORING DEVICES 89
8.2.7 OTHERS 90
8.3 AMBULATORY PATIENTS 90
8.3.1 MULTI-PARAMETER MONITORING DEVICES 91
8.3.2 RESPIRATORY MONITORING DEVICES 91
8.3.3 CARDIAC MONITORING DEVICES 91
8.3.4 BLOOD PRESSURE MONITORING DEVICES 91
8.3.5 BLOOD GLUCOSE MONITORING DEVICES 91
8.3.6 NEUROLOGICAL MONITORING DEVICES 91
8.3.7 OTHERS 92
8.4 HOSPITAL-BASED PATIENTS 92
8.4.1 MULTI-PARAMETER MONITORING DEVICES 93
8.4.2 CARDIAC MONITORING DEVICES 93
8.4.3 RESPIRATORY MONITORING DEVICES 93
8.4.4 BLOOD PRESSURE MONITORING DEVICES 93
8.4.5 BLOOD GLUCOSE MONITORING DEVICES 93
8.4.6 NEUROLOGICAL MONITORING DEVICES 93
8.4.7 OTHERS 94
9 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION 95
9.1 EUROPE 96
9.1.1 GERMANY 105
9.1.2 U.K. 109
9.1.3 FRANCE 113
9.1.4 ITALY 117
9.1.5 RUSSIA 121
9.1.6 SPAIN 125
9.1.7 TURKEY 129
9.1.8 SWITZERLAND 133
9.1.9 NETHERLANDS 137
9.1.10 BELGIUM 141
9.1.11 REST OF EUROPE 145
10 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE 146
10.1 COMPANY SHARE ANALYSIS: EUROPE 146
11 SWOT ANALYSIS 147
12 COMPANY PROFILE 148
12.1 MEDTRONIC 148
12.1.1 COMPANY SNAPSHOT 148
12.1.2 REVENUE ANALYSIS 149
12.1.3 COMPANY SHARE ANALYSIS 149
12.1.4 PRODUCT PORTFOLIO 150
12.1.5 RECENT DEVELOPMENT 150
12.2 DEXCOM, INC. 151
12.2.1 COMPANY SNAPSHOT 151
12.2.2 REVENUE ANALYSIS 151
12.2.3 COMPANY SHARE ANALYSIS 152
12.2.4 PRODUCT PORTFOLIO 152
12.2.5 RECENT DEVELOPMENT 152
12.3 ABBOTT 153
12.3.1 COMPANY SNAPSHOT 153
12.3.2 REVENUE ANALYSIS 153
12.3.3 COMPANY SHARE ANALYSIS 154
12.3.4 PRODUCT PORTFOLIO 154
12.3.5 RECENT DEVELOPMENT 154
12.4 RESMED 155
12.4.1 COMPANY SNAPSHOT 155
12.4.2 REVENUE ANALYSIS 155
12.4.3 COMPANY SHARE ANALYSIS 156
12.4.4 PRODUCT PORTFOLIO 156
12.4.5 RECENT DEVELOPMENT 156
12.5 BIOTRONIK SE & CO. KG 157
12.5.1 COMPANY SNAPSHOT 157
12.5.2 COMPANY SHARE ANALYSIS 157
12.5.3 PRODUCT PORTFOLIO 158
12.5.4 RECENT DEVELOPMENT 158
12.6 100 PLUS. 159
12.6.1 COMPANY SNAPSHOT 159
12.6.2 PRODUCT PORTFOLIO 159
12.6.3 RECENT DEVELOPMENTS 159
12.7 A&D COMPANY, LIMITED 160
12.7.1 COMPANY SNAPSHOT 160
12.7.2 REVENUE ANALYSIS 160
12.7.3 COMPANY SHARE ANALYSIS 161
12.7.4 PRODUCT PORTFOLIO 161
12.7.5 RECENT DEVELOPMENT 161
12.8 AEROTEL MEDICAL SYSTEMS 162
12.8.1 COMPANY SNAPSHOT 162
12.8.2 PRODUCT PORTFOLIO 162
12.8.3 RECENT DEVELOPMENT 162
12.9 ALIVECOR, INC. 163
12.9.1 COMPANY SNAPSHOT 163
12.9.2 COMPANY SHARE ANALYSIS 163
12.9.3 PRODUCT PORTFOLIO 163
12.9.4 RECENT DEVELOPMENTS 164
12.10 BIOBEAT 165
12.10.1 COMPANY SNAPSHOT 165
12.10.2 PRODUCT PORTFOLIO 165
12.10.3 RECENT DEVELOPMENT 165
12.11 BOSTON SCIENTIFIC CORPORATION 166
12.11.1 COMPANY SNAPSHOT 166
12.11.2 REVENUE ANALYSIS 167
12.11.3 COMPANY SHARE ANALYSIS 167
12.11.4 PRODUCT PORTFOLIO 167
12.11.5 RECENT DEVELOPMENT 168
12.12 CARDIOMO 169
12.12.1 COMPANY SNAPSHOT 169
12.12.2 PRODUCT PORTFOLIO 169
12.12.3 RECENT DEVELOPMENTS 169
12.13 CHRONISENSE MEDICAL, LTD. 170
12.13.1 COMPANY SNAPSHOT 170
12.13.2 PRODUCT PORTFOLIO 170
12.13.3 RECENT DEVELOPMENT 170
12.14 COACHCARE 171
12.14.1 COMPANY SNAPSHOT 171
12.14.2 PRODUCT PORTFOLIO 171
12.14.3 RECENT DEVELOPMENT 171
12.15 GENERAL ELECTRIC 172
12.15.1 COMPANY SNAPSHOT 172
12.15.2 REVENUE ANALYSIS 172
12.15.3 COMPANY SHARE ANALYSIS 173
12.15.4 PRODUCT PORTFOLIO 173
12.15.5 RECENT DEVELOPMENT 173
12.16 KONINKLIJKE PHILIPS N.V. 174
12.16.1 COMPANY SNAPSHOT 174
12.16.2 REVENUE ANALYSIS 174
12.16.3 COMPANY SHARE ANALYSIS 175
12.16.4 PRODUCT PORTFOLIO 175
12.16.5 RECENT DEVELOPMENT 175
12.17 MASIMO 176
12.17.1 COMPANY SNAPSHOT 176
12.17.2 REVENUE ANALYSIS 176
12.17.3 COMPANY SHARE ANALYSIS 177
12.17.4 PRODUCT PORTFOLIO 177
12.17.5 RECENT DEVELOPMENT 177
12.18 NETEERA 178
12.18.1 COMPANY SNAPSHOT 178
12.18.2 PRODUCT PORTFOLIO 178
12.18.3 RECENT DEVELOPMENT 178
12.19 NIHON KOHDEN CORPORATION 179
12.19.1 COMPANY SNAPSHOT 179
12.19.2 REVENUE ANALYSIS 179
12.19.3 COMPANY SHARE ANALYSIS 180
12.19.4 PRODUCT PORTFOLIO 180
12.19.5 RECENT DEVELOPMENT 180
12.20 OMRON CORPORATION 181
12.20.1 COMPANY SNAPSHOT 181
12.20.2 REVENUE ANALYSIS 181
12.20.3 COMPANY SHARE ANALYSIS 182
12.20.4 PRODUCT PORTFOLIO 182
12.20.5 RECENT DEVELOPMENT 182
12.21 SENSEONICS, INC. 183
12.21.1 COMPANY SNAPSHOT 183
12.21.2 REVENUE ANALYSIS 183
12.21.3 COMPANY SHARE ANALYSIS 184
12.21.4 PRODUCT PORTFOLIO 184
12.21.5 RECENT DEVELOPMENT 184
12.22 VITALCONNECT 185
12.22.1 COMPANY SNAPSHOT 185
12.22.2 PRODUCT PORTFOLIO 185
12.22.3 RECENT DEVELOPMENT 185
12.23 VITLS 186
12.23.1 COMPANY SNAPSHOT 186
12.23.2 PRODUCT PORTFOLIO 186
12.23.3 RECENT DEVELOPMENT 186
12.24 VIVIFY HEALTH INC. 187
12.24.1 COMPANY SNAPSHOT 187
12.24.2 PRODUCT PORTFOLIO 187
12.24.3 RECENT DEVELOPMENTS 187
12.25 WITHINGS 188
12.25.1 COMPANY SNAPSHOT 188
12.25.2 COMPANY SHARE ANALYSIS 188
12.25.3 PRODUCT PORTFOLIO 188
12.25.4 RECENT DEVELOPMENT 189
13 QUESTIONNAIRE 190
14 RELATED REPORTS 193
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security